BCOR mutations have been reported to co-occur with DNMT3A in over 40% of BCOR-mutated cases of AML, and a future larger study of these tumors may offer insights as to whether there is mutational synergy in CCS tumorigenesis28. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.